OMER: Omeros Corp. Kapitalizatsiyaning daromadga nisbati

Omeros Corporation (OMER) kompaniyasining korporativ logotipi

Omeros Corporation MASP-2 molekulalariga oid noyob patentlar tufayli yallig'lanishga qarshi nishada monopoliya saqlamoqda. Hozirgi vaqtda R&D bo'limi erta bosqichdagi tadqiqotlarni olg'a siljitgan holda, tartibga soluvchi o'zgarishlar tufayli kechikishlardan keyin klinik ma'lumotlarni ko'rib chiqmoqda. Biroq, yangi dori vositalarining ro'yxatdan o'tkazilishi rad etilishi xavfi va mavjud qarzdorliklar bosim o'stirmoqda. Tarixiy P/S dinamikasi biznes savdolarini baholashga yordam beradi, bunda joriy daraja 32.70 atrofida shakllangan.

OMER Omeros Corp Narxning daromadga nisbati (14.11.2022 - 16.11.2026)

Omeros Corporation (OMER) kompaniyasi koʻrsatkichlari kesimi va tahlili

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
Kompaniyaning fundamental tahlili:Omeros Corp., OMER
Omeros Corp. yetakchi tovari

Omeros Corporation (OMER) barqarorligi oftalmologiya dori vositalarining tijoratlashtirilishi va litsenziyalash shartnomalariga asoslangan bo'lib, bu tushumlar hajmini kapitalizatsiyaning asosiy drayveri qiladi. P/S koeffitsiyenti biznesning bozor qiymatini uning yillik savdolari bilan bog'laydi va investorning tushumning bir birligi uchun to'lashga tayyor bo'lgan premiumini o'lchaydi; shu bilan birga, narx/savdo koeffitsiyenti tendentsiyasi aktivning haddan tashqari sotib olinganligi yoki qadrsizlanganligini bildiruvchi baholash anomaliyalarini aniqlash imkonini beradi.

Raqobatdosh kompaniyalar

BIIB (Biogen) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NBIX (Neurocrine Corp)|Regencell Bioscience - Narxning daromadga nisbati|Axsome Therapeutics - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ACAD (ACADIA Pharmaceuticals)|Xenon (XENE) - Narxning daromadga nisbati|Sotuvga nisbatan narx Viking Therapeutics Inc (VKTX)|SUPN (Supernus Pharma) - P/S multiplikatori|CPRX: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori DNLI|Narx/daromad koeffitsiyenti Harmony Biosciences|Biohaven Ltd - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori Amylyx Pharmaceuticals, Inc. AMLX|TRVI: Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti Praxis Corp PRAX|AVXL: P/S multiplikatori|CBLL (ceribell.com) - Narxning daromadga nisbati|PRTA (Prothena Corporation) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati alector.com (ALEC)|Narxning daromadga nisbati Annexon, Inc. (ANNX)|Neurogene Corp - Kapitalizatsiya va daromad nisbati|Narxning daromadga nisbati AC Immune S.A. ACIU|Narx/daromad koeffitsiyenti Voyager Therapeutics (VYGR)|Neumora - P/S multiplikatori|Narxning sotuvga nisbati SCLX|Tevogen Bio Inc. (TVGN) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati ACOG|CGTX (cogrx.com) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati inhibikase.com (IKT)|Narxning daromadga nisbati Cassava Sciences Inc (SAVA)|Narx/daromad koeffitsiyenti Assertio|P/S multiplikatori COYA (Coya Therapeutics, Inc.)|Kapitalizatsiyaning sotish hajmiga nisbati VTGN (VistaGen Therapeutics Inc)|OVID: Kapitalizatsiyaning daromadga nisbati|ABOS: Narxning daromadga nisbati|CervoMed (CRVO) - Narxning daromadga nisbati|Sotuvga nisbatan narx Alterity Therapeutics Ltd (ATHE)|CLNN (Clene) - P/S multiplikatori|Kapitalizatsiya va daromad nisbati PEPG (PepGen)|Kapitalizatsiyaning daromadga nisbati JUNS (Jupiter Neurosciences, Inc.)|P/S multiplikatori relmada.com (RLMD)|Narxning daromadga nisbati Annovis Bio Corp ANVS|GRCE: Kapitalizatsiya va daromad nisbati|AIFF - Narxning daromadga nisbati|KLTO (anewmeds.com) - Kapitalizatsiya va daromad nisbati|NRSN (NeuroSense Therapeutics Ltd.) - Kapitalizatsiyaning daromadga nisbati|revivapharma.com - Bozor kapitallashuvining daromadga nisbati|MTVA (metaviatx.com) - P/S multiplikatori|NRXS: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori HSDT|PASG - Sotuvga nisbatan narx|P/S multiplikatori NEUP (Neuphoria Therapeutics)|NERV: Kapitalizatsiya va daromad nisbati|ATHA: Kapitalizatsiyaning daromadga nisbati|Addex Therapeutics Ltd - Kapitalizatsiyaning sotish hajmiga nisbati|Alzamend Neuro, Inc. (ALZN) - Narxning daromadga nisbati|CYCN (Cyclerion Therapeutics Inc.) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati PTIX|KTTA: Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati CRGT (Cortigent Medical)|ATXI (Avenue Therapeutics, Inc.) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Brainstorm Cell Therapeutics, Inc. BCLI|Bozor kapitallashuvining daromadga nisbati CARA|chromocell.com - P/S multiplikatori|Narxning sotuvga nisbati ELYM|ITCI: P/S multiplikatori|Sotuvga nisbatan narx Longboard Pharmaceuticals, Inc. (LBPH)|Narxning daromadga nisbati Marinus Pharmaceuticals, Inc.|NKGN: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NRBO|SAGE: Narxning sotuvga nisbati|Synaptogenix Inc. - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati TRVN (Trevena Inc.)|Vigil Neuroscience, Inc. - P/S multiplikatori|Anew Medical (WENA) - Kapitalizatsiyaning daromadga nisbati|CERE (Cerevel Corp) - Kapitalizatsiyaning daromadga nisbati